Industries > Pharma > Global Capnography Devices Market Report 2019-2029

Global Capnography Devices Market Report 2019-2029

Product (Hand-Held, Stand-Alone, Multi-Parameter), by Component (OEM Modules, Others), by Application (Emergency Medicine, Critical Care, Procedural Sedation, Pain Management, Others), by End User (Hospitals, Ambulatory Surgical Centers, Others), by Technology (Side Stream, Main Stream, Micro Stream) Company and Country Analysis and Forecasts

PAGES: 161
SUBMARKET: Medical Devices

WOOCS 2.2.1
SKU: PHA0466 Categories: , Tag:

Market Definition:
• Capnography are the type of devices which are used to monitor the concentration or partial pressure of carbon dioxide in the respiratory gases. These tools are used during anesthesia and intensive care.
• Capnography are highly used by EMS personnel to aid their assessment and treatment of patients in the pre-hospital environment.

Market Overview and Trends
• Rise in number of respiratory disease in developed regions will enhance the capnography devices market growth in the near future.
• The increasing development of portable/point-of-care capnography devices, increasing number of surgeries, clinical benefits of capnography equipment over pulse oximetry, and the evolving guidelines related to the clinical use of capnography are some of the factors which are driving the demand for capnography equipment during the forecast period.
• Based on devices market is classified into original equipment manufacturer (OEM) modules and others. The OEM modules segment is the dominating segment and is expected to be the fastest growing segment in the coming years. The utilization of OEM modules are is increasing in patient monitoring system manufacturers, due to their ability to provide additional functionality to the existing patient monitoring systems. OEM modules-based capnography devices can also make end-tidal CO2 or CO2 monitoring simple and accurate in the small and portable monitors
• Capnography devices are utilized in operating rooms to monitor ventilation during sedation.

Market Dynamics:

Factors Influencing the Market Growth:
• Rising number of respiratory diseases
• Rising preference of capnometers over oximetry
• Growing number of surgeries
• Increasing technological advancements

Factors Restraining the Market Growth:
• Lack of skilled professionals
• Stringent regulatory guidelines

Market Segmentation 2019-2029:

• OEM Modules Market, 2019-2029
• Others Market, 2019-2029

Usage Mode
• Hand-held Market, 2019-2029
• Stand-aloneMarket, 2019-2029
• Multi-parameter Market, 2019-2029

• Emergency MedicineMarket, 2019-2029
• Critical CareMarket, 2019-2029
• Procedural SedationMarket, 2019-2029
• Pain Management Market, 2019-2029
• Others Market, 2019-2029

End User
• HospitalsMarket, 2019-2029
• Ambulatory Surgical CentersMarket, 2019-2029
• OthersMarket, 2019-2029

• Side StreamMarket, 2019-2029
• Main Stream Market, 2019-2029
• Micro StreamMarket, 2019-2029
• MammographyMarket, 2019-2029

Geographic breakdown
Focused regional forecasts and analysis explore the future opportunities:
• North America Market, 2019-2029
• Europe Market, 2019-2029
• Asia-Pacific Market, 2019-2029
• Middle East Market, 2019-2029
• Africa Market, 2019-2029

Competitive Analysis:
• There are various companies operating in the capnography device market which are investing in development of advance technology and systems.
• North America is the dominating regional market for capnography equipment in 2018. The large target patient population in the region and the well-built presence of device manufacturers are the major factors which resulted in the significant adoption of capnography equipment in North America.
• Companies are strategically expanding their global presence and offering improved Capnography Devicetechnology. In October 2018, MasimoCorporation launch of Rad-97 Pulse Oximeter integrated with Nomoline. The company’s used this strategy to attract customer base via technological enhancement.

Major Market Players:
Smiths Medical; Dragerwerk AG & Co. KGaA.; Welch Allyn, Inc.; Masimo Corporation; Philips Healthcare; Medtronic, Inc.; Nonin Medical, Inc.; Nihon Kohden Corporation; CareFusion Corporation; and DiaMedica, Inc., Burtons Medical Equipment, Zoll Medical Corporation, Schiller AG, Becton, Dickinson and Company, Infinium Medical, Edan Instruments, Inc., Criticare Technologies, Inc., Edan Instruments Inc.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help:

Download sample pages

Complete the form below to download your free sample pages for Global Capnography Devices Market Report 2019-2029

Download sample pages

Complete the form below to download your free sample pages for Global Capnography Devices Market Report 2019-2029

Latest Pharma news

Visiongain Publishes Checkpoint Inhibitors for Treating Cancer Market Report 2021-2031

We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

29 July 2021


Visiongain Publishes Direct-to-Patient Market Report 2021-2031

Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.

21 July 2021


Visiongain Publishes Drug Delivery Technologies Market Report 2021-2031

Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.

20 July 2021


Visiongain Publishes Pharma Contract Sales Market Report 2021-2031

Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers’ operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use.

14 July 2021